Meeting details for Health

  • Date: Mar 27, 2012 - 4:00 PM
  • Chair: Kemp Hannon
  • Location: Room 124 CAP

Bills on the Agenda

S657A-2011: Makes possession and sale of embalming fluid a violation
Sponsor: VALESKY
AN ACT to amend the public health law, in relation to criminal possession and unlawful sale of embalming fluid
S2147-2011: Relates to the sale or purchase of human body parts
Sponsor: GOLDEN
AN ACT to amend the public health law, in relation to sales and purchases of human organs
S4255-2011: Excludes fundraising from consideration in appropriating state aid and reimbursement for services to volunteer ambulance companies
Sponsor: BONACIC
AN ACT to amend the public health law, in relation to excluding money raised by fundraising for volunteer emergency medical services when allocating state funding
S6694-2011: Establishes a synthetic cannabinoid and substituted cathinone surrender program and relates to controlled substances; repealer
Sponsor: FLANAGAN
AN ACT to establish a synthetic cannabinoid and substituted cathinone surrender program; to amend the public health law and the penal law, in relation to controlled substances; to repeal certain provisions of the public health law, relating to controlled substances; and providing for the repeal of certain provisions upon expiration thereof
S6742-2011: Establishes the New York state workgroup on Medicaid reimbursement for medically fragile children within the department of health
Sponsor: HANNON
AN ACT to amend the public health law, in relation to establishing the New York state workgroup on Medicaid reimbursement for medically fragile children
S6744-2011: Establishes a prescription pain medication awareness program within the department of health
Sponsor: HANNON
AN ACT to amend the public health law, in relation to establishing the prescription pain medication awareness program
S6745-2011: Provides that the initial prescription or dispensing of a controlled substance for acute pain shall be limited to a 3 - 10 day supply
Sponsor: HANNON
AN ACT to amend the public health law, in relation to limiting the initial prescription of a controlled substance for the alleviation of acute pain to a between three to ten day supply; and to amend the insurance law, in relation to coverage of such prescriptions